Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
First Claim
Patent Images
1. A method for treating arrhythmia in a human subject comprising the administration of a direct inhibitor of a multifunctional Ca2+/calmodulin-dependent protein kinase in an amount sufficient to suppress early afterdepolarizations, delayed afterdepolarizations, or intracellular calcium overload.
0 Assignments
0 Petitions
Accused Products
Abstract
This invention provides a method for treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions comprising a calcium/calmodulin-dependent protein kinase inhibitor and a pharmaceutically acceptable carrier and methods for identifying agents useful for the treatment of arrhythmias.
60 Citations
32 Claims
- 1. A method for treating arrhythmia in a human subject comprising the administration of a direct inhibitor of a multifunctional Ca2+/calmodulin-dependent protein kinase in an amount sufficient to suppress early afterdepolarizations, delayed afterdepolarizations, or intracellular calcium overload.
- 16. A method for preventing arrhythmia in a human subject comprising the administration of a direct inhibitor of a multifunctional Ca2+/calmodulin-dependent protein kinase in an amount effective to suppress early afterdepolarizations, delayed afterdepolarizations, or intracellular calcium overload.
- 31. A method for treating arrhythmia in a human subject, wherein said method comprises directly decreasing the Ca2+/calmodulin-dependent kinase activity level in said subject.
Specification